Dudediligence.

Natera, Inc

NTRANASDAQ · Services-Medical Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$439.8MSep ’24$476.1MDec ’24$501.8MMar ’25$546.6MJun ’25$592.2MSep ’25$665.5MDec ’25$696.6MMar ’26$752.8MJun ’26
Net income, by quarter
−$31.6MSep ’24−$53.8MDec ’24−$66.9MMar ’25−$100.9MJun ’25−$87.5MSep ’25$47.3MDec ’25−$85.1MMar ’26−$67.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$625.5M$820.2M$1.08B$1.70B$2.31B
Operating income−$468.2M−$541.0M−$446.2M−$222.3M−$309.9M
Net income−$471.7M−$547.8M−$434.8M−$190.4M−$208.2M
Operating cash flow−$335.2M−$431.5M−$247.0M$135.7M$215.3M
Free cash flow−$376.3M−$479.2M−$286.2M$69.2M$109.1M
Cash$84.6M$466.1M$642.1M$945.6M$1.08B
Debt$330.4M$362.0M$363.3M$80.4M$80.3M
Shares outstanding95.1M111.3M119.6M132.6M139.7M